Project Grant HT94252510930
- The University of California, San Diego (UCSD) was awarded a $1,197,884.00 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, awarded on Aug 15, 2025, supports research to investigate the mechanism and develop models of the human PD1 protein in the context of melanoma. As a leading academic institution, UCSD will leverage its expertise in medical research and education to conduct this advanced biomedical...
- The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
- The University of California, San Diego (UCSD) was awarded a $592,500.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy." The award, which spans from February 1, 2025 to January 31, 2028, aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UCSD, a...
- This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- The University of California, San Diego (UC San Diego) was awarded a $592,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 1, 2025, supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
- The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
- This federal Project Grant award of $437,967.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Diego (UCSD) focused on arterial disease in vascular Ehlers-Danlos syndrome and the potential role of oxidative stress. The award, effective January 1, 2025 through December 31, 2026, will fund comprehensive research services and scientific investigations at UCSD, a renowned...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,197,813.00 to the University of California, San Diego (UCSD) to conduct research on the mechanism and modeling of the human PD1 protein in melanoma. The award period runs from August 15, 2025 to August 14, 2028. UCSD, a leading academic medical research institution, will leverage its expertise in neuroscience, biomedical engineering, and healthcare to advance the scientific understanding and potential clinical applications of the PD1 protein in the treatment of melanoma. This grant award supports UCSD's broader mission of delivering specialized scientific research and innovative medical solutions to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 8/5/25 |